Preparation and quantification of pseudotyped retroviral vector

Methods in Molecular Biology

Volumn 433, Issue , 2008, Pages 1-15

  Yu, Hong ^a   Kwon, Young Jik ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Case Western Reserve University

Author keywords

Electron microscopy; Pseudotyped retrovirus; RT assay; Titration; Vesicular stomatitis virus G protein (VSV G); Viral vector

Indexed keywords

MURINAE; VESICULAR STOMATITIS VIRUS;

EID: 84934442012     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-237-3_1     Document Type: Article

References (30)

1. Miller, A. D., Miller, D. G., Garcia, J. V., and Lynch, C. M. (1993) Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217, 581-99.
2. Inaba, M., Toninelli, E., Vanmeter, G., Bender, J. R., and Conte, M. S. (1998) Retroviral gene transfer: effects on endothelial cell phenotype. J Surg Res 78, 31-6.
3. Zelenock, J. A., Welling, T. H., Sarkar, R., Gordon, D. G., and Messina, L. M. (1997) Improved retroviral transduction efficiency of vascular cells in vitro and in vivo during clinically relevant incubation periods using centrifugation to increase viral titers. J Vasc Surg 26, 119-27.
4. Friedmann, T., and Yee, J. K. (1995) Pseudotyped retroviral vectors for studies of human gene therapy. Nat Med 1, 275-7.
5. Schnell, M. J., Buonocore, L., Kretzschmar, E., Johnson, E., and Rose, J. K. (1996) Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci USA 93, 11359-65.
6. Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., and Yee, J. K. (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells [see comments]. Proc Natl Acad Sci USA 90, 8033-7.
7. Gallardo, H. F., Tan, C., Ory, D., and Sadelain, M. (1997) Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 90, 952-7.
8. An, D. S., Koyanagi, Y., Zhao, J. Q., Akkina, R., Bristol, G., Yamamoto, N., Zack, J. A., and Chen, I. S. (1997) High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells. J Virol 71, 1397-404.
9. Sharma, S., Cantwell, M., Kipps, T. J., and Friedmann, T. (1996) Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector. Proc Natl Acad Sci USA 93, 11842-7.
10. Liu, M. L., Winther, B. L., and Kay, M. A. (1996) Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J Virol 70, 2497-502.
11. Yu, H., Eton, D., Wang, Y., Kumar, S., Tang, L., Terramani, T., Benedict, C., Hung, G., and Anderson, W. (1999) High efficiency in vitro gene transfer into vascular tissues using a pseudotyped retroviral vector without pseudotransduction. Gene Ther 6, 1876-83.
12. Jang, J. E., Shaw, K., Yu, X. J., Petersen, D., Pepper, K., Lutzko, C., and Kohn, D. B. (2006) Specific and stable gene transfer to human embryonic stem cells using pseudotyped lentiviral vectors. Stem Cells Dev 15, 109-17.
13. Yu, J. H., and Schaffer, D. V. (2006) Selection of novel vesicular stomatitis virus glycoprotein variants from a peptide insertion library for enhanced purification of retroviral and lentiviral vectors. J Virol 80, 3285-92.
14. Guibinga, G. H., Hall, F. L., Gordon, E. M., Ruoslahti, E., and Friedmann, T. (2004) Ligand-modified vesicular stomatitis virus glycoprotein displays a temperaturesensitive intracellular trafficking and virus assembly phenotype. Mol Ther 9, 76-84.
15. Yee, J. K. (1999) Retroviral vectors. In The Development of Human Gene Therapy (Friedmann, T., Ed.), pp. 21-45, Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
16. Swaney, W. P., Novelli, E. M., Bahnson, A. B., and Barranger, J. A. (2002) Retrovirus-mediated gene transfer to human hematopoietic stem cells. In: Gene Therapy Protocols (J. R. Morgan, Ed.), 2nd Edition, pp. 187-202, Humana Press, Totowa.
17. Gliniak, B. C., Kozak, S. L., Jones, R. T., and Kabat, D. (1991) Disulfide bonding controls the processing of retroviral envelope glycoproteins. J Biol Chem 266, 22991-7.
18. Emi, N., Friedmann, T., and Yee, J. K. (1991) Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J Virol 65, 1202-7.
19. Schlegel, R., Tralka, T. S., Willingham, M. C., and Pastan, I. (1983) Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 32, 639-46.
20. Mastromarino, P., Conti, C., Goldoni, P., Hauttecoeur, B., and Orsi, N. (1987) Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH. J Gen Virol 68, 2359-69.
21. Conti, C., Mastromarino, P., Ciuffarella, M. G., and Orsi, N. (1988) Characterization of rat brain cellular membrane components acting as receptors for vesicular stomatitis virus. Brief report. Arch Virol 99, 261-9.
22. Chen, S. T., Iida, A., Guo, L., Friedmann, T., and Yee, J. K. (1996) Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system. Proc Natl Acad Sci USA 93, 10057-62.
23. Ory, D. S., Neugeboren, B. A., and Mulligan, R. C. (1996) A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA 93, 11400-6.
24. Arai, T., Matsumoto, K., Saitoh, K., Ui, M., Ito, T., Murakami, M., Kanegae, Y., Saito, I., Cosset, F. L., Takeuchi, Y., and Iba, H. (1998) A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines. J Virol 72, 1115-21.
25. Miller, D. G., Adam, M. A., and Miller, A. D. (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection [published erratum appears in Mol Cell Biol (1992) 12(1), 433]. Mol Cell Biol 10, 4239-42.
26. Kwon, Y. J., Hung, G., Anderson, W. F., Peng, C.-A., and Yu, H. (2003) Determination of infectious retrovirus concentration from colony-forming assay with quantitative analysis. J Virol 77, 5712-20.
27. Bierley, S. T., Raineri, R., Poiley, J. A., and Morgan, E. M. (1996) A comparison of methods for the estimation of retroviral burden. Dev Biol Stand 88, 163-5.
28. Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90, 8392-6.
29. Han, J. Y., Cannon, P. M., Lai, K. M., Zhao, Y., Eiden, M. V., and Anderson, W. F. (1997) Identification of envelope protein residues required for the expended host range of 10A1 murine leukemia virus. J Virol 71, 8103-8.
30. Soneoka, Y., Cannon, P. M., Ramsdale, E. E., Griffiths, J. C., Romano, G., Kingsman, S. M., and Kingsman, A. J. (1995) A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 23, 628-33.